Prognostic biomarkers can be direct or indirect to the causal pathway of a disease. If a prognostic biomarker is a direct step in the causal pathway, it is one of the factors or products of the disease.
Prognostic biomarkers can be considered to be either direct contributors to the disease process (being a factor or product) or indirect contributors (not being part of the causal pathway).